Impact of dendritic cells combining with cytokine-induced killer cells synergized chemotherapy in patients of advanced non-small cell lung cancer.
/in Dendritic Cells, NSCLC /von 2013-05-31 / J Clin Oncol 31, 2013 (suppl; abstr e19018)Vaccination of diffuse large B- cell lymphoma patients with antigen-primed dendritic cells
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2013-05-30 / Acta Med Iran 2013 May;51(5):284-8Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
/in International Publications, Micronutrients /von 2013-05-14 / Cancer Chemother. Pharmacol. 2013 Jul;72(1):139-46Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2013-05-01 / Anticancer Res. 2013 May;33(5):2047-56
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution